Table 1 Results of recent large studies with proton‐pump inhibitors, clarithromycin and amoxicillin triple therapy in Europe and the US.
First author | Total patients (n) | Duration (days) | ITT (95% CI) |
---|---|---|---|
Della et al9 | 812 | 7 | 72% (69% to 75%) |
Bochenek et al10 | 177 | 7 | 65% (56% to 73%) |
Boixeda et al11 | 890 | 7 | 77% (74% to 80%) |
Calvet et al8 | 237 | 7 | 76% (73% to 80%) |
Calvet et al8 | 210 | 10 | 79% (74% to 85%) |
De Francesco et al10 | 115 | 7 | 71% (63% to 79%) |
De Francesco et al12 | 116 | 10 | 80% (72% to 87%) |
Fennerty et al13 | 123 | 10 | 81% (73% to 87%) |
Fennerty et al13 | 126 | 14 | 82% (73% to 88%) |
Laine et al14 | 233 | 10 | 77% (71% to 82%) |
Scaccianoce et al15 | 70 | 7 | 75% (66% to 86%) |
Scaccianoce et al15 | 71 | 10 | 81% (73% to 91%) |
Vakil et al16 | 194 | 7 | 77% (71% to 83%) |
Vakil et al16 | 196 | 10 | 78% (72% to 84%) |
Vakil et al16 | 206 | 10 | 73% (67% to 79%) |
Zagari* et al | 301 | 7 | 79% (74% to 83%) |
Zagari* et al | 301 | 14 | 81% (77% to 85%) |
Zullo17 | 527 | 7 | 74% (70% to 77%) |
Zullo17 | 87 | 7 | 80% (72% to 88%) |
*ITT Current study being discussed.